Joan W. Miller, MD

Joan W. Miller Part of Expert Panel that Recommends Strategy Shift to Discover Dry AMD Treatments

July 26, 2019

A large-scale, collaborative, systems biology approach is needed to expedite the discovery of treatments for dry age-related macular degeneration, according to a report by a working group of scientists appointed by the National Advisory Eye Council (NAEC) that includes Joan. W. Miller, MD, Chair of Harvard Ophthalmology.

... Read more about Joan W. Miller Part of Expert Panel that Recommends Strategy Shift to Discover Dry AMD Treatments

Joan W. Miller—First Woman to Receive the Charles L. Schepens MD/American Academy of Ophthalmology Award

October 29, 2018

Headshot of Harvard Ophthalmology Chair Joan W. Miller

On October 26, Joan W. Miller, MD, the David Glendenning Cogan Professor and Chair of Ophthalmology at Harvard Medical School and the Chief of Ophthalmology at Massachusetts Eye and Ear and Massachusetts General Hospital, received the 2018 Charles L. Schepens, MD/American Academy of Ophthalmology (AAO) Award.... Read more about Joan W. Miller—First Woman to Receive the Charles L. Schepens MD/American Academy of Ophthalmology Award

Joan W. Miller, MD, Receives Howe Medal from American Ophthalmological Society

May 29, 2018

Joan W. Miller headhsotCelebrated award honors distinguished achievements in ophthalmology

Joan W. Miller, MD, the David Glendenning Cogan Professor and Chair of Ophthalmology at Harvard Medical School and Chief of Ophthalmology at Massachusetts Eye and Ear and Massachusetts General Hospital, has been named the 2018 recipient of the celebrated Lucien Howe Medal from the American Ophthalmological Society (AOS) for her distinguished service to the fields of retina and ophthalmology. ... Read more about Joan W. Miller, MD, Receives Howe Medal from American Ophthalmological Society

Scientists, Advocates Team Up to Launch Odylia Therapeutics to Accelerate Gene Therapy Trials for Rare Conditions Causing Blindness

March 7, 2018

New nonprofit organization will bring treatments to clinical trial for people at risk for blindness due to ultra-rare inherited retinal diseases.

Luk Vandenberghe in laboratory

Boston, Mass. — Scientists and advocates today announced the formation of ...

Read more about Scientists, Advocates Team Up to Launch Odylia Therapeutics to Accelerate Gene Therapy Trials for Rare Conditions Causing Blindness
The back of the eye in a patient with AMD, showing multiple large drusen deposits and pigment changes

Researchers identify potential biomarkers of age-related macular degeneration

September 12, 2017

Findings may lead to earlier diagnoses and better prognostic information for patients — and, potentially, new pharmaceutical targets for AMD treatment.

Boston, Mass. — Patients with any stage of age-related macular degeneration (AMD) carry signs of the disease in their blood that may be found through special laboratory tests, according to a new study led by AMD researchers based at Massachusetts Eye and Ear. The study, ...

Read more about Researchers identify potential biomarkers of age-related macular degeneration